Is it financially beneficial for hospitals to prevent nosocomial infections?

Table 5 Secondary outcomes: mortality, discharge and 90 day readmission

	CLABSI N (%)		CDI N (%)		SSI N (%)
	Case N = 62	Control N = 178	Case N = 92	Control N = 276	Case N = 76	Control N = 215
Discharge to LTCF	12 (19)	27 (15)	33 (36)	75 (27)	8 (11)	18 (8)
Hospital Mortality for first admission	35 (56)	75 (42)^$	24 (26)	30 (11)^$	1 (1)	1 (0.5)^$$$
Mortality within 90 days	36 (58)	87 (49)^$$	43 (47)	61 (22) ^$	2 (2)	1 (0.5)^$$$
90 days readmission^a	5/27 (18%)	31/103 (30%)	42/68 (62%)	85/246 (35%)	47/75 (62%)^b	32/214 (15%)^{$, c}
Mean length of stay per patient during readmission^a	1.5	4.3	16	4.4	7	0.5

^a Readmission data per number of patients discharged alive from first hospital stay
^b Seven patients (9%) required surgery during re-admission
^c Eight patients (4%) required surgery during re-admission
CLABSI central-line associated bloodstream infection, CDI clostridium difficile infection, SSI surgical site infection, LTCF long term care facility
Comparing cases to control $ p < 0.001, $$ p = 0.002, $$$ p = 1.0

ISSN: 1472-6963